View/Enter Patient Record. 3.1 CP-UC1-PS1 Refill Prescription (CASH)
|
|
- Roderick Garrison
- 5 years ago
- Views:
Transcription
1 3 CP-UC1 Dispense Prescription The community pharmacy use case group one (CP-UC1) contains workflows and activities that are focused on the dispensing of a medication to the patient. ID CP-UC1-PS1 CP-UC1-SS1 CP-UC1-SS2 CP-UC1-SS3 CP-UC1-SS4 CP-UC1-SS5 CP-UC1-SS6 CP-UC1-SS7 CP-UC1-SS8 Name Refill Prescription (CASH) Refill Prescription (Payor) Existing Patient, New Prescription New Patient, New Prescription Receive Prescription from Prescriber Receive Prescription via Transfer Reversal of Transaction (CASH) Reversal of Transaction (Payor) View/Enter Patient Record 3.1 CP-UC1-PS1 Refill Prescription (CASH) Business Overview Refilling a cash prescription involves first locating the client in the DIS, verifying their information for accuracy, and updating and/or confirming their allergies/intolerances. If the client has the prescription in hand (bottle or note), it can be located via the prescription number; otherwise the Pharmacist or Pharmacy Technician must review the prescription profile and/or the DIS, and identify which prescriptions have refills remaining and which prescription the client would like refilled. Once the prescription has been located, the worker can proceed in filling the prescription and having it signed off by the Pharmacist. The Pharmacist then counsels the client on the prescription they are receiving. Volume 3(a): Technical Rules 12
2 3.1.2 Workflow Technical Rules The profile must be requested and viewed prior to dispensing; The local system must display both locally dispensed and externally dispensed prescriptions in the same view; The local system must clearly indicate those prescriptions that were dispensed locally; and The local system must transmit the dispense to the DIS prior to third party payors. Volume 3(a): Technical Rules 13
3 3.1.4 Jurisdictional Variations PE As defined in workflows CP-UC1-SS2 and CP-UC1-SS3, the vendor software (local system) must send a new prescription to the DIS when new paper prescriptions that do not already exist electronically in the DIS are first transcribed in the local system. Following an individual store s integration to the DIS, there exists the scenario where new prescriptions were transcribed prior to DIS integration and subsequent refills need to be dispensed. In these situations, an electronic representation of the original prescription does not exist in the DIS. For refills falling into this scenario, the vendor software (local system) must send a new prescription to the DIS which represents the quantity remaining on the local prescription prior to the dispense in question. The new prescription message must precede the dispense message, and the dispense message must include the newly assigned DIS prescription ID. 3.2 CP-UC1-SS1 Refill Prescription (Payor) Business Overview Refilling a prescription that involves a third party begins with first locating the client in the DIS, verifying their information for accuracy, updating and/or confirming their allergies/intolerances, and entering or updating their third party information if required. If the client has the prescription in hand (bottle or note), it can be located via the prescription number; otherwise the Pharmacist (PhC) or Pharmacy Assistant (PA) may review the prescription profile and/or the DIS, and identify which prescriptions have refills remaining and which prescription the client would like refilled. The PA (or PhC) proceeds to process the Rx on the local system which is automatically transmitted to the DIS. The PhC views and manages the DUR from the DIS and continues to send the claim information to the Third Party Payor. The PhC views and manages the DUR from the Third Party Payor, assesses the fiscal adjudication from them and begins the manual preparation of the Rx. Once the prescription has been prepared, the PhC then checks the medication and signs the hardcopy of the Rx and the medication is stored until the patient or agent comes to pick it up at which time the PhC counsels the client on the prescription they are receiving and the patient pays the co-pay if one exists. Volume 3(a): Technical Rules 14
4 3.2.2 Workflow Technical Rules The profile must be requested and viewed prior to dispensing; The local system must display both locally dispensed and externally dispensed prescriptions in the same view; Volume 3(a): Technical Rules 15
5 The local system must clearly indicate those prescriptions that were dispensed locally; The local system must transmit the dispense to the DIS prior to third party payors Jurisdictional Variations PE As defined in workflows CP-UC1-SS2 and CP-UC1-SS3, the vendor software (local system) must send a new prescription to the DIS when new paper prescriptions that do not already exist electronically in the DIS are first transcribed in the local system. Following an individual store s integration to the DIS, there exists the scenario where new prescriptions were transcribed prior to DIS integration and subsequent refills need to be dispensed. In these situations, an electronic representation of the original prescription does not exist in the DIS. For refills falling into this scenario, the vendor software (local system) must send a new prescription to the DIS which represents the quantity remaining on the local prescription prior to the dispense in question. The new prescription message must precede the dispense message, and the dispense message must include the newly assigned DIS prescription ID. 3.3 CP-UC1-SS2 Existing Patient, New Prescription Business Overview The process of dispensing a new prescription consists of first locating the client in the system, verifying their information for accuracy, updating and/or confirming their allergies/intolerances, reviewing the patient s medication profile/history, entering the prescription into the system and filling the prescription. Before the prescription is dispensed to the patient, it is signed off by the Pharmacist and the patient is counselled by the Pharmacist on the medications they are receiving. Volume 3(a): Technical Rules 16
6 3.3.2 Workflow Technical Rules The local system must make electronic prescription available for use by the user; The local system must respect and enforce the current status (stopped, etc) recorded on the DIS for the prescription; The local system must provide a field to capture the Prescriber on the prescription screen; The local system must send the Prescriber in the Author element of the message and the PhC (or PA) in the Data Enterer element of the prescription message; The profile must be requested and viewed prior to dispensing; The local system must display both locally dispensed and externally dispensed prescriptions in the same view; The local system must clearly indicate those prescriptions that were dispensed locally; The local system must transmit the dispense to the DIS prior to third party payors Jurisdictional Variations N/A Volume 3(a): Technical Rules 17
7 3.4 CP-UC1-SS3 New Patient, New Prescription Business Overview The process of dispensing a new prescription for a new patient begins with locating the patient within the DIS, updating and/or confirming the patient s allergies/intolerances, reviewing the patient s medical profile and medical history. Once the patient s profile has been created and updated, the PA (or PhC) can begin entering the prescription into the system and filling the prescription. Before the prescription is dispensed to the patient, it is signed off by the Pharmacist and the patient is counselled by the Pharmacist on the medications they are receiving Workflow Technical Rules The local system must search using the provided Client Registry messages; The local system must identify potential matches between local data and Client Registry data; The local system must provide a field to capture the Prescriber on the prescription screen; The local system must send the Prescriber in the Author element of the message and the PhC (or PA) in the Data Enterer element of the prescription message; The local system must establish a linkage between the Health Number and the locally stored patient; The local system must permit the user to selectively import the name, date of birth, gender, addresses, phone numbers, and coverage; The local system must permit updates to be selectively submitted to the Client Registry. Volume 3(a): Technical Rules 18
8 3.4.4 Jurisdictional Variations PE Updates to the Client Registry are not supported; PE Non-Residents cannot be allocated Health Numbers from pharmacies; PE Non-Residents that visited a Provincial hospital or care facility will have a Health Number allocated. 3.5 CP-UC1-SS4 Receive Prescription from Prescriber Business Overview The process of dispensing a prescription that is received directly from a prescriber requires the Pharmacist to first verify the authority of the prescriber and validity of the prescription, and if the prescription is received over the telephone, the PhC must document the details of the Rx (a paper copy is required by law). Once the details of the prescription are finalized, the PA (or PhC) can proceed by locating the client in the system, verifying their information for accuracy, updating and/or confirming their allergies/intolerances, reviewing the patient s medication profile/history, entering the prescription into the system and filling the prescription. Before the prescription is dispensed to the patient, it is signed off by the Pharmacist and the patient is counselled by the Pharmacist on the medications they are receiving Workflow Volume 3(a): Technical Rules 19
9 3.5.3 Technical Rules The local system must support storing a prescription for a future fill without transmitting it to the DIS; Jurisdictional Variations N/A 3.6 CP-UC1-SS5 Receive Prescription via Transfer Business Overview Receiving a prescription due to a transfer from another pharmacy requires the Pharmacist to first locate the client in the system, review their patient profile and then contact the transferring Pharmacist via telephone to record the details of the transfer on a paper hard copy. Once the Pharmacist has verified the details of the transferred Rx, they can continue to enter the prescription into the system and fill the prescription. Before the prescription is dispensed to the patient, it is signed off by the Pharmacist and the patient is counselled by the Pharmacist on the medications they are receiving. It is important to note that the transferring Pharmacist must maintain a record of the transfer on their local system by either making use of their transfer function or by inactivating the transferred Rx Workflow Volume 3(a): Technical Rules 20
10 3.6.3 Technical Rules The local system must support dispensing against a transferred prescription; The local system must support releasing a prescription as part of the prescription transfer process Jurisdictional Variations N/A 3.7 CP-UC1-SS6 Reversal of Transaction (CASH) Business Overview The process of reversing a cash transaction requires the PA (or PhC) to retrieve the Rx or transaction record on the local system. Once the Rx/transaction record is retrieved, the PA (or PhC) sends the reversal request to the local system which must automatically update the DIS. The PA (or PhC) may provide a refund to the Pt/agent if required and may restock the medication if able based on the regulations of the local Pharmacy Board Workflow Technical Rules The local system must cancel the dispense event on the DIS; Volume 3(a): Technical Rules 21
11 3.7.4 Jurisdictional Variations N/A 3.8 CP-UC1-SS7 Reversal of Transaction (Payor) Business Overview The process of reversing a Third Party Payor prescription requires the PA (or PhC) to retrieve the Rx or transaction record on the local system. Once the Rx/transaction record is retrieved, the PA (or PhC) must send the reversal request to the Third Party Payor. If the reversal is accepted*, the PA (or PhC) can proceed to send the reversal request to the local system which must automatically update the DIS. The PA (or PhC) may provide a refund to the Pt/agent if required and may restock the medication if able based on the regulations of the local Pharmacy Board. *It should be noted that in the case where a reversal is not accepted, the PA (or PhC) may be required to call the third party helpdesk for a manual reversal and then proceed with the local system and DIS reversal. Volume 3(a): Technical Rules 22
12 3.8.2 Workflow Technical Rules The local system must cancel the dispense event on the DIS; The local system must reverse the dispense event for each third party payor submitted; The local system must support manually marking a dispense as DIS cancelled and/or TPP reversed in the event that a cancel/reverse was not electronically possible Jurisdictional Variations N/A 3.9 CP-UC1-SS8 View/Enter Patient Record Business Overview Virtually all activities relating to providing the patient with service require that you first locate, and potentially create, a patient record within the system. Volume 3(a): Technical Rules 23
13 3.9.2 Workflow Technical Rules The local system must support Client Registry searching using any combination of Health Number, Name, Date of Birth, and Gender; The local system must support provision of a keyword for profile access; The local system must search both local and Client Registry for matching records; The local system must merge patient records based on the Health Number; The local system must clearly indicate in search results whether the displayed records are stored locally or not; The local system should support the provision of a reason using values from the standard CeRx vocabulary for accessing a profile; The local system should support a user or system configurable list of reasons for accessing the profile Jurisdictional Variations PE The first name will be identified with qualifier attribute value of CL. The value CL is not meant to determine the first name - according to HL7, it is defined as a CALL ME name. However, it will be used to distinguish the first name from the middle name. In situations where a person goes by their middle name, the first name will still be distinguished as the 'call me' name with the value CL qualifier attribute. Volume 3(a): Technical Rules 24
Practice Direction Refill History Recording System
1.0 Scope and Objective: 1.1 Expected Outcome Practice Direction Refill History Recording System This document is a practice direction by Council concerning implementation of concept of prescription refill
More informationUser Guide for Transition to the Drug Information System
User Guide for Transition to the Drug Information System Document Revision History Date Description Version Updated By August 12, 2013 New/revised content 1.0 Lori Emery Version 1.0 Page 2 of 13 Table
More informationRefilling a Prescription with No Refills Remaining
................................................................................................... Refilling a Prescription with No Refills Remaining Pharmacy Technology Solutions May, 2013 Refilling
More informationNova Scotia Drug Information System
Nova Scotia Drug Information System Functions Presentation Details: Slides: 19 Duration: 00:32:04 Filename: DIS Module4.Functions.ppt Presenter Details: Slide 1 Nova Scotia Drug Information System Duration:
More informationA BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS
Pharmacy Benefact A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS Number 757 September 2018 Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2018/2019 This
More informationSECTION PRESCRIPTIONS
SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or
More informationCHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY
CHAPTER 1 COMMUNITY PHARMACY M.ASHOKKUMAR DEPT OF PHARMACY PRACTICE SRM COLLEGE OF PHARMACY SRM UNIVERSITY COMMUNITY PHARMACY OPERATIONS Technician Duties Related to Dispensing Over-the-Counter Drugs and
More informationDocumenting Patient Immunization. New Brunswick 2018/19
Documenting Patient Immunization New Brunswick 2018/19 Table of Contents Documenting Patient Immunization New Brunswick...3 Immunization Module Features...4 Configuration...5 Marketing Message Setup...6
More information2019 PHARMACY DIRECTORY
2019 PHARMACY DIRECTORY This is a brief explanation and overview of the pharmacies members can use to get their prescription drugs. In a continued effort to offer our members value, pharmacies may be added
More informationStudent Number. PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999
PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION 2 November 10, 1999 Questions 1-25 are multiple choice; please record answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions
More informationAppendix C NEWBORN HEARING SCREENING PROJECT
Appendix C NEWBORN HEARING SCREENING PROJECT I. WEST VIRGINIA STATE LAW All newborns born in the State of West Virginia must be screened for hearing impairment as required in WV Code 16-22A and 16-1-7,
More informationDocumenting Patient Immunization. Ontario 2018/19
Documenting Patient Immunization Ontario 2018/19 Table of Contents Documenting Patient Immunization Ontario...3 Immunization Module Features...4 Configuration...5 Marketing Message Setup...6 Paper Mode...9
More informationGeneral Providers. Tamper-Resistant Prescription Requirements
September 2008 Provider Bulletin Number 8138 General Providers Tamper-Resistant Prescription Requirements Effective with processing dates on and after October 1, 2008, written prescriptions for Kansas
More informationInitial Clinical History and Physical Form
601 E FM 544, Suite 400, Murphy, TX, 75094 TEL: 972-442-4700 Initial Clinical History and Physical Form Patient Information Name: Age: of Birth: / / Sex: Male / Female Marital Status: Single Married Divorced
More informationSection: Claims Payment - Cognitive Services (PAS Policy Administered by Drug Plan and Extended Benefits Branch)
Section: Claims Payment - Cognitive Services (PAS Policy Administered by Drug Plan and Extended Benefits Branch) Reference Date of Issue June 3, 2009 Approved by Director of Operations PACT Partnership
More informationA Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP)
A Step-by-Step Guide for Rubicon Pharmacists Delivering the RubiReview Program (SMAP) May 2014 RubiReview Program Overview... 3 Overview... 3 Adherence Packaging (RubiPaks)... 4 Eligibility... 4 Financial
More informationPART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition)
1305.16 1305.16 Special procedure for filling certain order forms. (a) The purchaser of carfentanil etorphine hydrochloride or diprenorphine shall submit copy 1 and 2 of the order form to the supplier
More informationOverview. Ontario Public Drug Programs, Ministry of Health and Long-Term Care
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Frequently Asked Questions for Pharmacists October 2015 Pharmacist Administration of the Publicly Funded Influenza Vaccine and Claims
More information2018 PHARMACY DIRECTORY
2018 PHARMACY DIRECTORY This is a brief explanation and overview of the pharmacies members can use to get their prescription drugs. In a continued effort to offer our members value, pharmacies may be added
More informationAppendix 11 Roles and Responsibilities October, 2013 Page 1 of 5
October, 2013 Page 1 of 5 Exposed Person To present to a health care facility as soon as possible following the exposure (ideally within 2 hours). To answer assessment questions. (Refer to Appendix 15
More informationMedsCheck Reviews. Ontario
MedsCheck Reviews Ontario Contents Configuration... 1 Configuring Electronic Signatures... 1 Configuring Electronic MedsCheck Reviews... 2 Creating an ODB MedsCheck Consent Record... 3 Electronic MedsCheck
More information2018 PHARMACY DIRECTORY
2018 PHARMACY DIRECTORY This is a brief explanation and overview of the pharmacies members can use to get their prescription drugs. In a continued effort to offer our members value, pharmacies may be added
More informationPolling Question # 3. DISCLOSURE STATEMENT Pharmacy Immunizations How to Stay Competitive and in Compliance LEARNING OBJECTIVES
DISCLOSURE STATEMENT Pharmacy Immunizations How to Stay Competitive and in Compliance R. JEFFREY HEDGES President & CEO I, Jeff Hedges, disclose that I am employed as a consultant at R.J. Hedges & Associates.
More informationCDC Immunization Project (CNI) Test Plan September 28, 2015
CDC Immunization Project (CNI) Test Plan September 28, 2015 1 CNI Test Plan Bidirectional Exchange 3.4.1.2 Contents 1. Initial Data Load... 5 1.1 Juana Mariana Gonzales Initial Data Load... 5 1.1.1 Step
More informationUsing CURES to combat prescription drug abuse/misuse
Using CURES to combat prescription drug abuse/misuse Speakers Nathan Painter PharmD, CDE Email: npainter@ucsd.edu Rabia Atayee, PharmD, BCPS Email: ratayee@ucsd.edu UC San Diego Skaggs School of Pharmacy
More informationQuestions and answers about HCA s opioid clinical policy for Apple Health (Medicaid)
Questions and answers about HCA s opioid clinical policy for Apple Health (Medicaid) This Q&A covers questions the Health Care Authority (HCA) received during webinars about the opioid clinical policy
More informationPatientLink MyLinks FHIR. Page 1 of 8. HIMSS Interoperability Showcase 2019
Use Case Title: Patient Centered Interoperability Short Description: Leo Simpson is a 42 year old auto body painter with asthma and pre-diabetes. He utilizes a personal health record (PHR) to manage, aggregate,
More information1Oxford Contact Overview. Contact Information at a Glance... 11
1Oxford Contact Overview Contact Information at a Glance.......... 11 Oxford Contact Overview Section 1 10 www.oxfordhealth.com Oxford Contact Overview Section 1 Contact Information at a Glance Electronic
More informationPHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List
Overview The management of outpatient prescription drugs is an integral part of the medical management program to improve the health and well-being of our members. Prescriber and member involvement is
More informationPreparing for Electronic Prescribing of Controlled Substances (EPCS) in New York
Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York Ken Whittemore, Jr. R.Ph., MBA Senior VP, Professional & Regulatory Affairs Copyright Copyright 2015 by 2015 Surescripts,
More informationTechnical Assistance Guide No Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations
Technical Assistance Guide No. 02-14 Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations This project was supported by Grant No. 2011-PM-BX-K001 awarded by
More informationPharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.
Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education
More informationGeneral Terms and Conditions
General Terms and Conditions Revision history (November 2007) Date issued Replaced pages Effective date 11/07 ii, iii, 2, 4 11/07 11/06 all pages 11/06 01/06 all pages 01/06 02/05 ii, iii, 4, 7 8 02/05
More informationE-Prescribing, EPCS & PDMP: An Update
E-Prescribing, EPCS & PDMP: An Update Melissa A. Kotrys, MPH Chief Executive Officer July 27, 2018 Arizona Health-e Connection is now Health Current Arizona s primary resource for health information technology
More information2018 PHARMACY DIRECTORY
2018 PHARMACY DIRECTORY This is a brief explanation and overview of the pharmacies members can use to get their prescription drugs. In a continued effort to offer our members value, pharmacies may be added
More informationNarcotics Monitoring System (NMS) Update
Narcotics Monitoring System (NMS) Update DISCLOSURE OF COMMERCIAL SUPPORT This program has received no financial or in-kind support. Potential for conflict(s) of interest: None Faculty/Presenter Disclosure
More informationYour Prescription Card. Your guide for savings.
CVS Caremark 620 Epsilon Drive Pittsburgh, PA 15238 4750-_PM 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 Your Prescription Card. Your guide for savings. Dear Plan Member, Welcome to your new benefits. Attached
More information2018 PHARMACY DIRECTORY
2018 PHARMACY DIRECTORY This is a brief explanation and overview of the pharmacies members can use to get their prescription drugs. In a continued effort to offer our members value, pharmacies may be added
More informationWhat Do IACP Members Think?
What Do IACP Members Think? Results of a National Survey of Compounding Practitioners February 27, 2013 Final Summary Results What Do Compounders Think? National Survey of 2,857 pharmacists and technicians
More informationNew patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit:
The Novo Nordisk Diabetes Patient Assistance Program (PAP) provides medication to qualifying applicants at no charge. If the applicant qualifies under the Novo Nordisk Diabetes PAP guidelines, a 120-day
More informationTechnician Tutorial: Dispensing Insulin and Other Injectable Meds
(Page 1 of 6) Technician Tutorial: Dispensing Insulin and Other Injectable Meds Insulin is a hormone secreted by the pancreas. It helps the body use glucose as an energy source. Insulin acts like a key
More informationMaine PMP Update. Daniel Eccher, MPH MPA Convention May 20, 2011
Maine PMP Update Daniel Eccher, MPH MPA Convention May 20, 2011 Outline for presentation Prescription drug abuse indicators Basic overview of PMP PMP s new web site and registration requirements Using
More informationDIRECTORY Pharmacy
2017 Pharmacy DIRECTORY This is a brief explanation and overview of the pharmacies members can use to get their prescription drugs. In a continued effort to offer our members value, pharmacies may be added
More informationHOSPICE INFORMATION FOR MEDICARE PART D PLANS
HOSPICE INFORMATION FOR MEDICARE PART D PLANS SECTION I -HOSPICE INFORMATION TO OVERRIDE AN HOSPICE A3 REJECT OR TO UPDATE HOSPICE STATUS A. Purpose of the form (please check all appropriate boxes) : Admission
More informationMarijuana Guidelines
America s Foremost Insurance Brokerage Network AIG No more than twice per year: Best class if otherwise qualified. Up to twice a month: Standard Non-Tobacco rates More often: Tobacco rates, and maybe rated
More informationMedicare Part D Opioid Policies for 2019 Information for Patients
CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Opioid Policies for 2019 Information for Patients Introduction Prescription opioid pain medications like oxycodone (OxyContin ), hydrocodone (Vicodin
More informationSANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery
Section Sub-section Policy Policy# Pharmacy SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Pyxis MedStation Controlled Substances 17.102 Page 11 of 5 Programmatic
More informationuniversity client training program
COURSE OFFERINGS university client training program Dear Valued Client, Since our inception in 1997, TSI Healthcare has followed a guiding principle that support and training do not end after implementation.
More informationMichigan Automated Prescription System
MAPS Michigan Automated Prescription System Accuracy of Data Edits applied. Most at 95% Two full time technicians. Two part time students. Full time analyst One shared tech and PT programmer. Data uploads
More informationPharmacy Audit Recovery Guidelines
1/1E DAW 1 DAW 1 Error The prescription order does not indicate the prescriber ordered brand name. 2 /2E DAW 2 DAW 2 Not Documented The documentation does not specify the patient s request for brand. Pharmacy
More information-decreased bone Adherence iprex study. -protective effect
HIV Pre-Exposure Prophylaxi is (PrEP): A brief guide for providers Daily emtricitabine/tenofovir (Truvada ) is safe and effectivee for reducing the risk of HIV acquisition in sexually active men and women
More informationStark County Safety Council Presentation: Opioid & Anti-Anxiety Medication Use Among Ohio s Injured Workers
Stark County Safety Council Presentation: Opioid & Anti-Anxiety Medication Use Among Ohio s Injured Workers June 11, 2015 John Hanna, R.Ph. BWC, Pharmacy Director 6/24/2015 BWC Pharmacy Program Overview
More informationUnderstanding Your Patient Care Opportunity Report (PCOR)
Understanding Your Patient Care Opportunity Report (PCOR) Use your January/February 208 PCOR to help improve performance on Medicare Part D Clinical Star Ratings measures. Your January/February 208 Patient
More informationAlthough PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states.
NASCSA Statement for the Record as presented by Barbara A Carter, President, NASCSA Submitted to: Department of Health and Human Services, Food and Drug Administration, Opioid Policy Steering Committee
More informationNew Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers
CENTERS FOR MEDICARE & MEDICAID SERVICES New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers Background CMS understands the magnitude of the nation s opioid epidemic and
More informationMethadone 8.3. Dispensing (Ontario) This document describes the recommended way to setup and dispense Methadone mixtures.
Methadone 8.3 Dispensing (Ontario) This document describes the recommended way to setup and dispense Methadone mixtures. Last Updated: February 15, 2010 Table of Contents Methadone Drug and Mixture Card
More informationNew Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program Express Scripts Holding Company. All Rights Reserved.
New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program 1 About Express Scripts Express Scripts is RHCA s chosen partner for administering your prescription plan We are a leading
More informationPBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.
Speaker Brian K. Solow, MD, FAAFP Optum Life Sciences Irvine, CA, USA PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Brian K. Solow, MD, FAAFP Chief Medical Officer, Optum Life Sciences
More informationPrescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study
Prescription Drug Importation: Can it Help America's Seniors? Safety of Imported Medications: I-SaveRx Case Study Presented By: Scott McKibbin Special Advocate For Prescription Drugs State Of Illinois
More information5 DAY SUPPLY LIMIT OF PRESCRIPTION OPIOID MEDICATIONS
5 DAY SUPPLY LIMIT OF PRESCRIPTION OPIOID MEDICATIONS 1. Members under the age of 18: a. Except as otherwise specified in Section (1)(b), Conditions and Care Exclusion from the 5 day Supply Limitation
More information4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP
New Mexico s Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy New Mexico and the PMP In 2012, New Mexico had the 3 nd Highest Overdose Death Rate in Nation.! 492 Deaths or a rate of 23.6
More informationQUALITY IMPROVEMENT TOOLS
QUALITY IMPROVEMENT TOOLS QUALITY IMPROVEMENT TOOLS The goal of this section is to build the capacity of quality improvement staff to implement proven strategies and techniques within their health care
More informationArkansas Prescription Monitoring Program
Arkansas Prescription Monitoring Program ONE YEAR UPDATE Scott Pace, Pharm.D., Esq. Special Thanks Thanks to Denise Robertson at the Arkansas Department of Health for supplying the PMP data for this presentation
More informationDIRECTORY Pharmacy
2017 Pharmacy DIRECTORY This is a brief explanation and overview of the pharmacies members can use to get their prescription drugs. In a continued effort to offer our members value, pharmacies may be added
More informationThe Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division
The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able
More informationTexas Vendor Drug Program Specialty Drug List Process. February 2019
Texas Vendor Drug Program Specialty Drug List Process February 2019 Table of Contents Table of Contents...1 1 About the Specialty Drug List...2 1.1 Information for Pharmacies... 2 1.2 Information for Managed
More informationTracker e-prescribing 101. The Complete Guide
Tracker e-prescribing 101. The Complete Guide Copyright Stratum Access Technologies, Inc. 2017 www.stratumaccess.com Electronic prescribing, known in short as e-prescribing, is a method of prescription
More informationCalifornia. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationWelcome to your. Pharmacy Services Guide. Many of our stores are open 24 hours. To find one near you, visit or call SHOP CVS.
Welcome to your Many of our stores are open 24 hours. To find one near you, visit www.cvs.com or call 1-800-SHOP CVS. Pharmacy Services Guide 06530RXS09 - Item #456748 11/08 Supplying you with health information
More informationYour Prescription Card. Your guide for savings.
3 Paragon Drive Montvale, NJ 07645 >00001 00001 001 P50708 _PM 7873 GROUP JOHN Q SAMPLE 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 APDNCLDJDKDIFPAKHPANEMFK AJCLLKEBEKNJJBNMPKGOKIKK AMBPIBPEAKHEIOBKFGFBOMMK
More information4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update
Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov
More informationNaloxone and Combating the Opioid Epidemic
Objectives Naloxone and Combating the Opioid Epidemic Jeff Jacobson PharmD Southpointe Pharmacy Discuss the current opioid crisis Define the role of Naloxone in opioid overdose Analyze the barriers to
More informationDo not open the test booklet prior to being told to do so.
Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources
More informationMedicare Part D Overutilization Monitoring System
Medicare Part D Overutilization Monitoring System Lisa Thorpe, Division of Part D Policy Gary Wirth, Division of Clinical and Operational Performance Medicare Drug Benefit and C&D Data Group July 17, 2013
More informationChallenges for U.S. Attorneys Offices (USAO) in Opioid Cases
Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being
More informationComprehensive Outreach Education Certificate Program. & Health Modules. Spring 2014
Comprehensive Outreach Education Certificate Program & Health Modules Community Health Education Center Lowell Community Health Center 161 Jackson Street Lowell, MA 01852 Tel: 978-452-0003 Fax: 978-221-6215
More information2018 PHARMACY DIRECTORY
2018 PHARMACY DIRECTORY List of network pharmacies This directory is a partial list of network pharmacies near your ZIP code. Changes to our pharmacy network may occur during the benefit year. An updated
More informationFREQUENTLY ASKED QUESTIONS PHARMACISTS
FREQUENTLY ASKED QUESTIONS PHARMACISTS Q. Why did the College update standards for methadone maintenance treatment (MMT)? A. The College updated standards for MMT in collaboration with PharmaCare and other
More informationYour Prescription Card. Your guide for savings.
Kent State University P.O. Box 5190 Kent, OH 44242-0001 13578-00001_PM JOHN Q SAMPLE 2215 SANDERS RD NBT 2215-5 NORTHBROOK, IL 60062 Your Prescription Card. Your guide for savings. 00001 Dear Plan Member,
More informationCARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:
RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription
More informationRECEIVING YOUR PERMANENT
00001 JOHN Q SAMPLE 9501 E. Shea Blvd SCOTTSDALE, AZ 85260 3118-00001_PM City of Savannah 132 E. Broughton Street Savannah, GA 31401 THIS IS A ONE-TIME CARD TO BE USED UNTIL YOUR PERMANENT CARD ARRIVES
More informationMedicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists
CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists Background Opioid medications are effective at treating certain types of pain,
More informationCrowe Healthcare Webinar Series
Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President
More informationD9995 and D9996 ADA Guide to Understanding and Documenting Teledentistry Events
D9995 and D9996 ADA Guide Version 1 July 17, 2017 Page 1 of 10 D9995 and D9996 ADA Guide to Understanding and Documenting Teledentistry Events Developed by the ADA, this guide is published to educate dentists
More informationPATIENT SIGNATURE: DOB: Date:
CINCINNATI PAIN PHYSICIANS, LLC (CPP) ACKNOWLEDGEMENT OF RECEIPT OF NOTICE OF PRIVACY PRACTICES By signing below, I acknowledge that I have received a copy of CPP s Notice of Privacy Practices. The Notice
More informationADHD Information and Instructions
ADHD Information and Instructions This ADHD information packet will answer many of the questions you may have concerning your child s appointment. Please read everything carefully prior to your visit and
More informationBritish Columbia Data Standards
British Columbia Data Standards Minimum Immunization Data Set Interoperability Guide Version: 1.0 October 23, 2017 Sponsors PHSA: Jill Reedijk Canada Health Infoway DOCUMENT CONTROL DOCUMENT HISTORY Version
More informationNATPARA (parathyroid hormone) for injection Risk Evaluation and Mitigation Strategy (REMS) Program
NATPARA (parathyroid hormone) for injection Risk Evaluation and Mitigation Strategy (REMS) Program PRESCRIBER TRAINING MODULE 1 Contents Introduction NATPARA (parathyroid hormone) for injection Indication
More informationSPECIAL DISCLAIMER FOR INTERPRETING SERVICES INVOLVING CALLS TO EMERGENCY SERVICE PROVIDERS (911/E911), OR LEGAL, MEDICAL OR MENTAL HEALTH ISSUES
SPECIAL DISCLAIMER FOR INTERPRETING SERVICES INVOLVING CALLS TO EMERGENCY SERVICE PROVIDERS (911/E911), OR LEGAL, MEDICAL OR MENTAL HEALTH ISSUES Governing Language. The English language version of this
More informationChanges to the Eighth Edition
Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,
More informationHL7 s Version 2 standards and submission to immunization registries
HL7 s Version 2 standards and submission to immunization registries Alean Kirnak Cochair HL7 Public Health and Emergency Response Workgroup American Immunization Registry Association Software Partners
More informationREGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY A Pharmacist s Guide
REGIONAL PHARMACY SPECIALIST SMOKING CESSATION SERVICE FEBRUARY 2009 A Pharmacist s Guide Aims of the Service The overall aim of the service is to deliver a pharmacy based, one stop specialist smoking
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) District of Columbia Information contained in this presentation is accurate as of September 2017 Meet the Speaker Tadessa Harper-Nichols Program Specialist Pharmaceutical
More informationA Bulletin for PHARMACY Service Providers from Alberta Blue Cross. Alberta Public Health Activities Program (APHAP)
harmacy Benefact A Bulletin for HARMACY Service roviders from Alberta Blue Cross Number 479 September 2014 Alberta ublic Health Activities rogram (AHA) As in past years, pharmacists are invited to participate
More informationApril 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director
More informationWhat is Quitline Iowa?
CONTENTS: What is Quitline Iowa? 0 A telephone counseling helpline for tobacco-use cessation. Free to all residents of the state of Iowa Open Monday-Thursday 7:00am 12:00am / Friday 7:00am 9:00pm / Saturday
More informationThis Frequently Asked Questions document contains various aspects of UIIP in the following sections. Overview Eligibility...
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Frequently Asked Questions for Pharmacists October 2017: Pharmacist Administration of the Publicly Funded Influenza Vaccine and Claims
More information